CELL-BASED ASSAYS

PROXENCELL Laboratories at

Center for Clinical Genomics and Personalised Medicine (http://genomics.med.unideb.hu/),

Medical and Health Sciences Center, University of Debrecen

 in cooperation with 

UD-GenoMed MEDICAL GENOMIC TECHNOLOGIES Ltd. (http://www.ud-genomed.hu)

are continuously developing technologies and solutions which are essential in the process of biosimilar development and market entry.

Our portfolio include:

REPORTER AND EFFECTOR BIOASSAY CELL LINES - stable/genome engineered custom cell lines expressing cell surface markers suitable for complex bioassays in

- biosimilar development and production QC

- to support FDA & EMEA approval  of biosimilars via the in vitro

PRODUCER CELL LINES – stable/genome engineered cell lines (HEK/CHO) expressing at high levels of recombinant proteins (industrial scale)

- for biosimilar production

- for recombinant protein production

BIOASSAYS - for biosimilar development and production QC

- ADCC

- CDC

- GRANZYME B

- PHAGOCYTOSIS

 CELL LINE TRACEABILITY AND QC ASSAYS for

- cell line identification

- genetic stability

- transgene characterisation

- complex process QC